Table 2.

Changes of thyroid function before and after short-acting octreotide inhibition test.

Patients	Before SSA			After SSA 72h
	TSH (μIU/mL)	FT3 (pmol/L)	FT4 (pmol/L)	TSH (μIU/mL)	FT3 (pmol/L)	FT4 (pmol/L)
Case 1	5.613	13.37	48.72	0.39	8.16	40.03
Case 2	6.854	12.08	30.05	0.279	5.72	21.3
	5.077	11.25	27.58	1.555	8.91	25.14
Case 3	4.73	14.59	60.03	1.06	9.26	54.9
Case 4	28.956	4.57	14.73	17.36	3.92	15.2
	6.649	3.96	18.13	7.222	4.35	17.46

Normal ranges: TSH 0.49–4.91 μIU/mL; FT3 3.28–6.47 pmol/L; FT4 7.64–16.03 pmol/L.

FT3, free tri-iodothyronine; FT4, free thyroxine; SSA, somatostatin analog; TSH, thyroid-stimulating hormone.